10 years of the WIN Symposium
10 years of the WIN Symposium
Future EU framework programmes
Precision approaches for immunotherapy
The breakthrough drug designation, patients driving progress
Beyond standard of care: the next steps of Precision Oncology
21st century medicine is transforming healthcare and the diagnosis and treatment of cancer
The TAPUR trial family: a global data sharing platform
The 10th Anniversary of the WIN Consortium: lessons and perspectives
Biobanking and early diagnosis to defeat NSCLC
Patients access to precision oncology
Early development in oncology: Are the MTD and monotherapy efficacy still the best objectives?
U.S. National Cancer Institute perspective on precision oncology
WINTHER & SPRING: Targeted agents and triple agent combinations
Precision medicine in newly diagnosed breast cancer
Lessons from long-term survey of stage I NSCLC
MyPathway study: a novel precision oncology multiple basket trial
Implementing precision medicine in oncology: The IMPACT trials
Precision CAR T cell therapeutics